Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Press Release: Annual General Meeting of April 30, 2024
Annual General Meeting of April 30, 2024Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board composition: renewal of two Directors and appointment of three new Independent DirectorsParis, April 30, 2024. The Combined General Shareholders' Meeting of Sanofi was held on April 30, 2024, under the chairmanship of Frédéric Oudéa. All resolutions submitted to the vote were adopted by the...
Nasdaq GlobeNewswire
30/04/2024
Dermabrasion and Microneedling Market Size to Grow USD 684.4 Million by 2031 at…
The Global Dermabrasion and Microneedling Market size was valued at USD 417.7 Million in 2021, and is projected to reach USD 684.4 Million by 2031, growing at a CAGR of 5.1% from 2022 to 2031. The Global Dermabrasion and Microneedling Market size was valued atUSD 417.7 Millionin 2021, and is projected to reachUSD 684.4 Millionby 2031, growing at a CAGR of 5.1% from 2022 to 2031. Get Free Sample:...
PR Newswire
30/04/2024
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI…
LOS ANGELES and AMSTERDAM, April30, 2024(GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (Nasdaq: RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing (ULP-WGS) of cell-free DNA (cfDNA), Flamingo represents a promising leap forward in the fight...
Nasdaq GlobeNewswire
30/04/2024
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps…
Following a Fast Track Designation by the FDA in late 2022 for Oncolytics Biotech Inc.'s (NASDAQ: ONCY) (TSX: ONC) drug candidate, pelareorep, for pancreatic cancer treatment, the company is now gaining traction towards another pivotal FDA engagement, this time focusing on breast cancer. Recently, Oncolyticsannounced that they had submitted a Type C meeting request to the FDA to discuss a forthcoming trial for pelareorep aimed at treating HR+/HER2- metastatic breast cancer (mBC) patients…
PR Newswire
30/04/2024
More than 55,821 Units of Construction Equipment to be Sold Across Brazil -…
Brazil Construction Equipment Market Report Scope Brazil Construction Equipment Market Report Scope Brazilis the largest market inLatin America. The country accounted for 40% of overall construction equipment sales in the region in 2023.Brazilis the center of construction equipment manufacturing in the continent. All major construction equipment OEMs have a manufacturing center in theSao Pauloregion of the country. Vendors are signing exclusive partnerships with end-users to...
PR Newswire
30/04/2024
Pharmaceutical Glass Packaging Market to Attain a US$ 54.6 Billion Valuation by…
The demand for less invasive therapies is increasing. As a result, consumable tablets are more in demand. Similarly, other less invasive capsules and other medicines observe a spike in demand. Consequently, the demand for packaging solutions is increasing, driving the growth of the pharmaceutical glass packaging market. The demand for less invasive therapies is increasing. As a result, consumable tablets are more in demand. Similarly, other less invasive capsules and other medicines observe a...
PR Newswire
30/04/2024
Dental Bone Graft Substitutes Market Worth $1.8 billion | MarketsandMarkets™
This report divides dental bone graft substitute into four segments – type, application, mechanism, product, end user and region. This report divides dental bone graft substitute into four segments – type, application, mechanism, product, end user and region. Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690 Browse in-depth TOC on "Dental Bone Graft Substitutes Market" 260 - Tables 50 - Figures 400 - Pages Dental Bone...
PR Newswire
30/04/2024
Countries With Low and Middle Income Populations are Exhibiting Comparatively…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19549 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19549 Demand for barbiturate drugs is observing a steady increase due to their use in the treatment of epilepsy, insomnia, and anxiety. The surging geriatric population is another key factor responsible for the growth...
PR Newswire
30/04/2024
LILYSILK Unveils 2024 Summer Collection "State of Wonder", A Tapestry of…
The collection's flagship products include: The collection's flagship products include: LILYSILK also introduces must-have colors and items for the summer: Mother's Day Special CampaignCelebrating mothers all over the world, fromApril 12th to May 13th, LILYSILK is offering an exclusiveMother's Day Campaignon its website: "At LILYSILK, we believe in embracing the open road ahead and seizing the boundless moments of wonder that each new horizon presents," saidDavid Wang, CEO...
PR Newswire
30/04/2024
Smart Mouthguards and Anti-Aging Lights - IDTechEx Explores Wearables
Sporting injuries Sporting injuries Sport is a large sector for the wearables market, but it gets better than simply wearing a smartwatch. Contact sports such as rugby have opened a gap in the market forsmart mouthguards. This basic piece of equipment has long been used for safety, but now by installing tiny sensors, they have been developed to assess the force and impact upon players' heads during play to get a better understanding of injury and concussion. For some rugby positions,...
PR Newswire
30/04/2024
Nicklaus Children's Health System, Philips to provide innovative patient and…
Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidenceAmsterdam, the Netherlands, and Miami, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nicklaus Children's Health System, a nationally recognized leader in pediatric care, today announced a 10-year long-term strategic collaboration aimed at enhancing the patient and staff...
Nasdaq GlobeNewswire
30/04/2024
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
The notice convening the general meeting, including the agenda and the board's proposals to the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders with known addresses. The notice convening the general meeting, including the agenda and the board's proposals to the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders with known addresses. Relevant documents referred to in the notice are made available...
PR Newswire
30/04/2024
Roborock Teams Up with "The Garfield Movie" to Give Garfield a More Pampered…
Through a multi-medium creative campaign which will include product placement in the film, a TVC, out of home, digital and social media placements, the leading entertainment franchise and robotic vacuum leader will join forces to bring their collective audiences together, highlighting how one of the world's most beloved cats, together with his fans across the globe, can all benefit from Roborock's suite of automated home cleaning solutions. "Rocking Life, With You" is more than just a…
PR Newswire
30/04/2024
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their…
Medison, the creator and leader of the multi-regional partnership category, has established a unique, unified commercialization platform in international markets, particularly for the treatment of rare and severe diseases. Medison is the only partner that focuses solely on the most innovative therapies. Alnylam and Medison initially partnered in 2018. Ever since, the partnership has expanded to additional regions and markets, to ensure that Alnylam's commercial therapies, such as...
PR Newswire
30/04/2024
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye…
LONDON and NEW YORK, April30, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, today announced an upcoming presentation of the OK-101 Phase 2 data for dry...
Nasdaq GlobeNewswire
30/04/2024
Global Scaffold Technology Market is set to expand at a CAGR of 11.3% until 2034…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16020 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-16020 The scaffold technology industry is propelled by advancements in tissue engineering and regenerative medicine technologies that augment demand for scaffold materials. The aging population and rising healthcare...
PR Newswire
30/04/2024
In Vitro Fertilization Market Projected to Reach US$ 1,940.8 Million Valuation…
The amplifying consciousness regarding infertility and the accessibility of alternative medications are the determining catalysts obligated to augment the in vitro fertilization market growth. Factors like the attainability of innovative products, boosting male infertility, escalating utilization of cigarettes and alcohol, and elevating government schemes to strengthen IVF treatment reinforce segment growth. The amplifying consciousness regarding infertility and the accessibility of…
PR Newswire
30/04/2024
Shareholders approve all resolutions proposed by Board of Directors at Annual…
All proposals of Board of Directors approvedGilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for election confirmedMathai Mammen, Graeme Pitkethly and Michael Rechsteiner elected as new Board membersDividend of CHF 0.45 per registered dividend-paying share approved, representing 24% of core net incomeBasel, April 30, 2024– Sandoz (SIX: SDZ; OTCQX: SDZNY) today announced that its shareholders approved all proposals of the Board of...
Nasdaq GlobeNewswire
30/04/2024
Cognitive Health Research Leads to a Flourishing Serine Amino Acid Market with a…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19554 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19554 Serine is an essential component of purine and pyrimidine biosynthesis. Serine is the most common one-carbon unit used to produce S-adenosylmethionine through methylation. In tetrahydrofolate methylation...
PR Newswire
30/04/2024
Photocure ASA: Annual Report 2023
The documents are enclosed and also made available at the company's website under https://photocure.com/investors-hub/investors-events-and-presentations. The documents are enclosed and also made available at the company's website underhttps://photocure.com/investors-hub/investors-events-and-presentations. For further information, please contact: Photocure CFOErik DahlTel: +47 450 55 000 Email:
[email protected]
About Photocure ASA: Photocure: The Bladder Cancer Company...
PR Newswire
30/04/2024
SpinEM Robotics and Spineart Forge Strategic Partnership with €10 Million…
Stephane Morvan, CEO of SpinEM Robotics, highlighted the significance of the collaboration, stating: "Led by industry visionary Stéphane Lavallée, SpinEM Robotics has developed groundbreaking technologies that will redefine the standard of care in navigated and robotically enabled spinal surgery. Our solutions seamlessly integrate human-robot interfaces, enhancing surgical precision and efficiency." Stephane Morvan, CEO of SpinEM Robotics, highlighted the significance of the…
PR Newswire
30/04/2024
Zymeworks Announces Participation in Upcoming Investor Conferences
Bank of America Securities Health Care Conference: Zymeworks' management will participate in one-on-one meetings on May 15 thin Las Vegas, NV.J.P. Morgan Biotech Virtual Call Series: Zymeworks' management will participate in a virtual fireside chat on May 15 that 10:00 am Pacific Time.About Zymeworks Inc.Zymeworks is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks' mission is to...
Nasdaq GlobeNewswire
30/04/2024
CDR-Life Announces Fourth Milestone Achievement with Boehringer Ingelheim in…
CDR-Life Inc.today announced the advancement of the Phase 1 study with BI 771716, its therapeutic candidate in partnership with Boehringer Ingelheim (BI) for the treatment of geographic atrophy (GA). This marks the achievement of the fourth milestone under the collaboration and licensing agreement between BI and CDR-Life. BI 771716 is an antibody fragment-based compound. Its reduced size enables optimized retinal layer-penetration to the most critical target site driving GA disease...
Nasdaq GlobeNewswire
30/04/2024
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with…
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech's U.S. commercialization agreement with Teva PharmaceuticalsThe high-concentration interchangeable biosimilar to Humira® manufactured by Alvotech will be distributed under Quallent's private-label REYKJAVIK, ICELAND, PARSIPPANY, N.J., and TEL AVIV, ISRAEL (April 30, 2024)— Alvotech (NASDAQ:...
Nasdaq GlobeNewswire
30/04/2024
Altri Comunicati